To explore the cellular responses to mtDNA stress in the absence of OXPHOS deficiency, we employed a TFAM heterozygous knockout (*Tfam+/−*) mouse model. Cells and tissues from these animals exhibit modest or no significant differences in mtDNA-encoded transcripts and oxygen consumption rates, despite \~50% depletion of mtDNA ([Extended Data Fig. 1a--c](#F5){ref-type="fig"})^[@R5],[@R6]^. In addition to mtDNA depletion, *Tfam+/−* mouse embryonic fibroblasts (MEFs) have reduced oxidative mtDNA damage repair capacity and markedly altered mtDNA packaging, organization, and distribution ([Fig. 1a](#F1){ref-type="fig"})^[@R6]^. Nucleoids in *Tfam+/−* MEFs were less numerous and exhibited a larger size distribution ([Fig. 1a](#F1){ref-type="fig"} and [Extended Data Fig. 1d](#F5){ref-type="fig"}). Thus, *Tfam+/−* cells provide a robust model to characterize cellular responses triggered by moderate mtDNA stress.

Gene expression profiling of *Tfam+/−* MEFs revealed an unexpected enrichment of interferon-stimulated genes (ISGs) and antiviral signaling factors ([Fig. 1b](#F1){ref-type="fig"}). Of the 45 most over expressed genes, 39 were ISGs, including many with direct antiviral activity (i.e. *Ifi44*, *Ifit1*, *Ifit3*, *Oasl2*, *Rtp4*)^[@R7],[@R8]^. There was also increased expression of cytoplasmic RNA and DNA sensors, such as *Ddx58* (RIG-I), *Ifih1* (MDA5), and p200 family proteins *Ifi203*, *Ifi204*, and *Ifi205*, as well as transcription factors *Irf7*, *Stat1*, and *Stat2*, ISGs that function to positively reinforce the antiviral response. Direct measurement of basal ISG mRNA and protein expression in *Tfam+/−* MEFs validated the microarray results ([Fig. 1c--d](#F1){ref-type="fig"}). Finally, *Tfam+/−* MEFs expressed 3--4 fold more *Ifnb and Ifna4* upon transfection with the MDA5 agonist poly(I:C) ([Fig. 1e](#F1){ref-type="fig"}), consistent with enhanced type I interferon responses.

To ensure that the mtDNA stress and ISG expression phenotypes were not unique to *Tfam+/−* MEFs, we employed inducible TFAM depletion models (TF^D^). Analogous to *Tfam*+/− cells, TF^D^ MEFs and bone marrow-derived macrophages (BMDM) displayed mtDNA stress phenotypes, augmented ISG expression, and heightened type I interferon responses to poly(I:C) ([Extended Data Fig. 1d--i](#F5){ref-type="fig"}). Collectively, these data indicate that TFAM depletion induces mtDNA nucleoid stress that triggers antiviral 'priming,' characterized by basally elevated ISG expression and potentiated type I interferon production.

Since mitochondrial stress can trigger release of mtDNA into the cytosol to engage the NLRP3 inflammasome, we assayed for extra-mitochondrial mtDNA in TF^D^ cells^[@R9],[@R10]^ . Analysis of pure cytosolic extracts revealed a 3--4 fold increase of specific mtDNA fragments from the D-loop regulatory region, indicating liberation of immunostimulatory mtDNA into the cytosol ([Extended Data Fig. 2](#F6){ref-type="fig"})^[@R11]^. Confocal and electron microscopy of TF^D^ cells revealed significantly elongated, interconnected mitochondrial networks consistent with a hyperfused phenotype ([Fig. 1a](#F1){ref-type="fig"} and [Extended Data Figs. 1e, g](#F5){ref-type="fig"}, [3a--b](#F7){ref-type="fig"}). Since mitochondrial fission facilitates proper nucleoid distribution and removal of damaged mtDNA, we examined whether mitochondrial hyperfusion in TF^D^ cells governed mtDNA stress-induced ISG expression^[@R12],[@R13]^. Knockdown of mitofusin-1 (Mfn1) induced fission and largely abrogated ISG expression in TF^D^ MEFs ([Extended Data Fig. 3c--e](#F7){ref-type="fig"}). Moreover, depletion of the mtDNA quality-control enzyme endonuclease G-like 1 (EXOG) exacerbated ISG expression in *Tfam+/−* MEFs ([Extended Data Fig. 3f](#F7){ref-type="fig"})^[@R14]^. Collectively, these data indicate that TFAM depletion promotes accumulation of aberrant mtDNA, which accesses the cytosol to engage innate immune signaling.

We next examined the involvement of the cytosolic DNA sensor cGAS in mtDNA stress signaling, as it mediates ISG expression in response to exogenous and endogenous immunostimulatory DNA species^[@R15]--[@R17]^. Knockdown of cGAS in *Tfam+/−* MEFs or TFAM depletion in *cGas−/−* MEFs largely abrogated ISG expression ([Fig. 2a](#F2){ref-type="fig"}). Furthermore, ISG mRNAs in TF^D^ cells were reduced 70--90% in the absence of STING, indicating cGAS-STING signaling is the predominant driver of mtDNA stress-induced ISG expression ([Fig. 2b](#F2){ref-type="fig"}). STING signals via the TBK1-IRF3/7 axis to trigger antiviral gene expression, and knockdown of either TBK1 or IRF3 robustly blocked ISG expression in *Tfam+/−* MEFs ([Fig. 2c--d](#F2){ref-type="fig"})^[@R18],[@R19]^. This was accompanied by enhanced nuclear accumulation of IRF3, consistent with IRF3 activating ISG transcription ([Fig. 2e](#F2){ref-type="fig"}). Finally, using murine cGAS reconstituted *cGAS−/−* MEFs, we observed prominent re-localization of cGAS from nuclear and/or cytoplasmic pools to the vicinity of aberrant mtDNA nucleoids in TF^D^ MEFs ([Fig. 2f--g](#F2){ref-type="fig"}). Taken together, these results indicate that mtDNA stress facilitates cGAS-dependent sensing of cytoplasmic mtDNA, resulting in STING-TBK1-IRF3 signaling to trigger ISG expression.

To establish functional significance of mtDNA stress-induced antiviral priming, we challenged MEFs with Herpes Simplex Virus-1 (HSV-1) or Vesicular Stomatitis virus (VSV) that express GFP for easy detection. In contrast to WT cells, which displayed robust viral GFP expression post-infection, *Tfam+/−* MEFs were markedly resistant to HSV-1 and VSV ([Fig. 3a](#F3){ref-type="fig"}). In addition, *Tfam+/−* MEFs exhibited heightened type I interferon and ISG expression upon viral challenge, consistent with potentiated type I interferon responses in these cells ([Extended Data Fig. 4a](#F8){ref-type="fig"}). Similar results were obtained upon challenge with the rodent gamma-herpesvirus MHV-68 ([Fig. 3b](#F3){ref-type="fig"} and [Extended Data Fig. 4b](#F8){ref-type="fig"}). Furthermore, TF^D^ BMDM displayed augmented antiviral gene expression and markedly lower HSV-1- and VSV-encoded mRNA and protein 6--24 hours post infection ([Extended Data Fig. 5c--f](#F9){ref-type="fig"}). Finally, we found that *Tfam+/−* mice exhibit basally elevated ISG expression, which confers resistance to acute infection by lymphocytic choriomeningitis virus (LCMV) Armstrong ([Extended Data Fig. 5a](#F9){ref-type="fig"} and [Fig. 3c](#F3){ref-type="fig"}).

To probe a direct requirement for mtDNA stress in antiviral priming in TFAM deficient cells, we utilized dideoxycytidine (ddC), a deoxyribonucleoside analog that specifically inhibits mtDNA replication and decreases mtDNA nucleoid size^[@R2],[@R20]^. Treatment of WT MEFs with ddC resulted in reduced mtDNA copy number and decreased average nucleoid size without altering basal ISG expression ([Extended Data Fig. 5b--d](#F9){ref-type="fig"}). In contrast, ddC drastically diminished mtDNA stress (i.e. enlarged nucleoids measuring greater than 450nm^2^) in *Tfam+/−* and TF^D^ MEFs ([Fig. 3d](#F3){ref-type="fig"} and [Extended Data Fig. 5e](#F9){ref-type="fig"}), which was accompanied by attenuation of antiviral priming and basal ISG expression ([Fig. 3e](#F3){ref-type="fig"} and [Extended Data Fig. 5d, f](#F9){ref-type="fig"}). Moreover, ddC ablated the viral resistance phenotype of *Tfam+/−* MEFs ([Fig. 3f](#F3){ref-type="fig"}). We observed similar decreases in type I interferon production and a reduction in the viral resistance phenotype in ddC-treated TF^D^ BMDM ([Extended Data Fig. 5g--h](#F9){ref-type="fig"}, blue bars). These results demonstrate that mtDNA stress directly potentiates antiviral innate immunity.

The observation that ddC treated WT BMDM displayed reduced *Ifnb* and increased viral gene expression upon challenge with HSV-1, despite normal responses to cytosolic nucleic acids ([Extended Data Fig. 5h--i](#F9){ref-type="fig"}, gray bars), indicated to us that virus-induced mtDNA stress may boost host antiviral responses, consistent with reports linking viral infection to mtDNA dysregulation^[@R21],[@R22]^. The alpha-herpesvirus protein UL12.5 encoded by HSV-1 and HSV-2 localizes to mitochondria and promotes rapid mtDNA depletion in human cells, which we confirmed in MEFs ([Extended Data Fig. 6a](#F10){ref-type="fig"})^[@R22]--[@R24]^. Since mtDNA depletion and nucleoid stress are often coupled, we explored nucleoid architecture and abundance kinetically during HSV-1 infection. Remarkably, 3 hours after challenge with HSV-1, mtDNA stress was readily apparent, with nucleoids less evenly distributed and enlarged ([Fig. 4a](#F4){ref-type="fig"}). After 6 hours, \~10% of nucleoids measured larger than 450 nm^2^, and there was a significant decrease in total nucleoid intensity. After 12 hours, we observed pronounced mtDNA depletion. The mtDNA stress observed 3 to 6 hours after HSV-1 challenge closely mirrored that of TFAM deficient cells ([Fig. 4b](#F4){ref-type="fig"}), as did TFAM protein levels ([Fig. 4c](#F4){ref-type="fig"}). MHV-68 and HSV-2 triggered mtDNA stress similar to HSV-1, indicating that mtDNA stress is a common cellular perturbation during herpesvirus infection ([Extended Data Fig. 6b--c](#F10){ref-type="fig"}). However, induction of mtDNA stress and TFAM depletion were not a general consequence of viral infection, as cells infected with VSV, Influenza, LCMV, and Vaccinia possessed normal mtDNA architecture, TFAM expression, and copy number ([Fig. 4a--c](#F4){ref-type="fig"} and [Extended Data Fig. 6c--d](#F10){ref-type="fig"}).

Finally we sought to determine whether HSV-1-induced mtDNA dysregulation is necessary and sufficient to potentiate antiviral signaling. Transduction of MEFs and BMDM with replication-incompetent retroviruses encoding the mitochondria-targeted HSV-1 UL12 M185 gene product was sufficient to cause mitochondrial hyperfusion, nucleoid enlargement, and mtDNA loss, indicative of mtDNA stress ([Fig. 4d](#F4){ref-type="fig"} and [Extended Data Fig. 7a](#F11){ref-type="fig"})^[@R24]^. UL12 M185 expression was also sufficient to trigger TFAM depletion and antiviral priming (i.e. augmented ISG mRNA and protein expression) ([Fig. 4e](#F4){ref-type="fig"} and [Extended Data Fig. 7a](#F11){ref-type="fig"}). To explore the effect of HSV-1-induced mtDNA stress on innate antiviral responses, we employed a recombinant, UL12-deficient HSV-1 strain (UL12Δ + UL98-FLAG) that is severely impaired in its ability to induce mtDNA stress but replicates similarly to a matched UL12-sufficient strain ([Extended Data Fig. 7b--c](#F11){ref-type="fig"})^[@R25]^. Infection with UL12Δ HSV-1 resulted in attenuated phospho-TBK1, type I interferon and ISG expression between 3 to 6 hours post infection, despite comparable early HSV-1 gene expression ([Fig. 4f--g](#F4){ref-type="fig"}). However, after 24 hours, UL12Δ HSV-1 genome abundance was roughly three fold higher compared to the UL12-suficient control, consistent with impaired antiviral innate immunity ([Fig. 4h](#F4){ref-type="fig"}). Finally, UL12Δ HSV-1 elicited less robust antiviral innate immune responses in the vagina and more readily spread to dorsal root ganglia of WT mice due to a deficit in mtDNA stress-dependent antiviral priming ([Extended Data Fig. 7d--e](#F11){ref-type="fig"}). These results reveal that herpesvirus-induced mtDNA stress is necessary to effectively engage ISG expression and antiviral priming, and suggest that cellular monitoring of mtDNA homeostasis may represent an additional sensory mechanism to robustly engage antiviral innate immunity.

In closing, our work uncovers a novel cellular response to mtDNA stress that engages the antiviral innate immune response. Specifically, we show that mtDNA stress, induced by herpesvirus infection and mediated by loss of the mtDNA packaging protein TFAM, triggers a cGAS-STING-IRF3-dependent pathway to upregulate ISGs and potentiate type I interferon responses to viral infection ([Extended Data Fig. 8](#F12){ref-type="fig"}). Our results support a model whereby viral-mediated disruption of mtDNA homeostasis serves as a cell-intrinsic indicator of infection that works in parallel with canonical virus sensing to fully license antiviral innate immunity. Conversely, pathologic type I interferon signatures promote autoimmune diseases such as systemic lupus erythematosus (SLE), and altered ISG expression correlates with radiation-resistant and metastatic phenotypes in some cancers^[@R26],[@R27]^. Mitochondrial and mtDNA dysregulation have been noted in SLE, and perturbations in TFAM and/or mtDNA homeostasis are frequently observed in cancer^[@R28]--[@R30]^. Therefore, further investigation into this pathway will not only expand our knowledge of innate antiviral defense, but it may also broaden our understanding of how mitochondria contribute to the pathogenesis of human diseases and aging beyond their well-characterized roles in metabolism, apoptosis, and reactive oxygen species production.

On-line only Methods {#S1}
====================

Animal Strains {#S2}
--------------

*Tfam+/−* and *Tfam^flox/flox^* mice were previously described and maintained on a C57BL/6 background^[@R6],[@R31]^. *Tfam^flox/flox^* mice were bred to ERCre transgenic mice from Jackson (stock \# 004682) for inducible, 4OHT-mediated deletion. All animal experiments were conducted in compliance with guidelines established by the Yale University Animal Care and Use Committee.

Antibodies and Reagents {#S3}
-----------------------

Rabbit anti-mouse TFAM polyclonal anti-sera was previously described^[@R6]^, rabbit anti-VSV polyclonal anti-sera was a gift of John Rose at Yale University, mouse anti-Viperin was a gift of Peter Cresswell at Yale University, and rabbit-anti IFIT3 was a gift of Ganes Sen at Cleveland Clinic. The following antibodies were obtained commercially: goat anti-Hsp60 (N-20) and rabbit anti-Calnexin (H-70) (Santa Cruz Biotechnology); mouse and rabbit anti-FLAG (F1804, F7425) (Sigma); mouse anti-DNA (CBL186) (Millipore); mouse anti-GFP (JL-8) (BD Biosciences); rabbit anti-HSV1/2 (ab9533) and anti-Histone 3 (ab1791) (Abcam); rat anti-HA-FITC (11988506001) (Roche); rabbit anti-NLRX1 (17215-1-AP) (Proteintech); mouse anti-α-tubulin (DM1A) (Neomarkers); mouse anti-GAPDH (6C5) (Ambion); and rabbit anti-RIG-I (D14G6), -MDA5 (D74E4), -STAT1 (9172), -IRF3 (D83B9), -TBK1 (D1B4), and -phospho-TBK1 (D52C2) (Cell Signaling Technology). mIFNα ELISA and recombinant mIFNβ was from PBL Assay Science, and mIL-6 ELISA was from eBioscience. All primer sequences and siRNAs utilized are found in [Extended Data Tables 1](#T1){ref-type="table"}--[2](#T2){ref-type="table"}.

Cell Culture {#S4}
------------

Primary WT, *Tfam+/−*, *Sting−/−*, and *cGas−/−* MEFs were generated from E12.5--14.5 embryos, maintained in DMEM (Invitrogen) supplemented with 10% FBS (Atlanta Biological), and subcultured no more than five passages before experiments. *Sting−/−* MEFs were kindly provided by Dr. Glen Barber at the University of Miami^[@R32]^. L929 cells were obtained from ATCC and maintained in DMEM supplemented with 10% FBS. siRNA transfection of MEFs was performed with 25 nM siRNA duplexes (IDT) and Lipofectamine RNAiMAX reagent (Invitrogen) according to the manufacturer's instructions. ddC (Sigma) was resuspended in PBS, added to MEFs or BMDM at a final concentration of 10--20 µM, and replenished every 48 hours. BMDM were generated from bone marrow of 8--12 week old littermate *Tfam^fl/fl^ERCre−* and *Tfam^fl/fl^ERCre+* mice and cultured on Petri plates in DMEM containing 10% FBS plus 30% L929 culture media. To induce Cre-mediated deletion, 1 µM 4OHT dissolved in DMSO (Sigma) was added to BMDM cultures on day 6 and incubated for an additional 2--3 days. Cells were then lifted from plates by incubating in cold PBS containing 1 mM EDTA, re-plated in fresh media containing 10% L929 conditioned media, and allowed to rest overnight before experimentation (for a total of 72 or 96hrs 4OHT exposure). Transfection of ISD^[@R33]^ and Poly(I:C) (Sigma) into the cytosol of BMDM was performed using Lipofectamine 2000 (Invitrogen). Briefly, 1×10^6^ BMDM were seeded in 6-well dishes after 4OHT treatment, and transfected the next day with 4µg ISD/well or 2.5µg/well of Poly(I:C) complexed at a ratio of 2:1 Lipofectamine 2000 to nucleic acid. Poly(I:C) transfection into the cytosol of MEFs was performed as described^[@R34]^.

Viral Stocks and Infections {#S5}
---------------------------

VSV-G-GFP^[@R35]^, HSV1-GFP^[@R36]^, MHV-68-GFP, HSV2^[@R37]^, Vaccinia virus^[@R38]^, Influenza A PR8 NS1-GFP^[@R39]^, HSV1 (UL12-FLAG) and HSV1 (UL12Δ + UL98-FLAG)^[@R25]^ were maintained as described^[@R34],[@R40],[@R41]^. MEFs or BMDM were infected at the indicated multiplicity of infection (MOI) in serum-free DMEM for one hour, washed, and incubated for various times. Cells were then fixed and stained for microscopy, lysed for western blot, solubilized in RLT plus (Qiagen) for RNA extraction, or prepared for FACS analysis. FACS was performed by first trypsinizing MEFs, followed by labeling with LIVE/DEAD Fixable Far Red stain (Molecular Probes). Cells were then fixed with 4% paraformaldehyde, washed, and analyzed on a FACSCalibur flow cytometry machine (BD). FACS plots were first gated on live cells before analyzing viral GFP fluorescence. Viral gene expression in BMDM was determined using qRT-PCR as described below, except that after values were normalized against GAPDH cDNA using the 2^−ΔΔCt^ method, all data points were subtracted by one to center on zero.

LCMV ARM infection of WT and *Tfam+/−* mice was performed as described^[@R42]^. Briefly, 10-week-old female mice were infected with 2 × 10^5^ p.f.u. of virus i.p., and four days post infection, mice were sacrificed, tissues isolated, and total RNA prepared using RNeasy Plus kits (QIAGEN). After generating cDNA, samples were subjected to qPCR analysis as described below using published methods^[@R43],[@R44]^.

In Vivo HSV-1 Infection, DRG isolation, and Viral Titration {#S6}
-----------------------------------------------------------

6-week old female mice were purchased from Charles River Laboratories and treated with Depo Provera (GE Healthcare) five days before infection^[@R45]^. The vaginal canals of Depo Provera treated mice were swabbed with a Calginate swab (Fisher) and 10^6^ plaque forming units were delivered via pipette tip into the vagina. One day post infection, vaginal tissue was isolated for RNA extraction. Infected mice were euthanized at indicated time points and dorsal root ganglia (DRG) were dissected as previously described^[@R46]^. DRG were homogenized using a motorized pestle and total DNA was isolated using the DNeasy Blood & Tissue Kit (Qiagen) according to the manufacturer's instructions. Relative HSV-1 genome abundance was determined using primers specific for nuclear *Tert* and HSV-1 *TK*.

cGAS-HA and UL12 M185 Cloning and Retroviral Expression {#S7}
-------------------------------------------------------

A plasmid encoding HSV1 UL12 M185 SPA containing a 3X FLAG tag at the C-terminus was described previously^[@R24]^. This construct, or a plasmid encoding murine cGAS-HA (Invivogen), was subcloned into the pMXs-IRES-Puro vector and replication incompetent retroviruses were packaged using plat-E cells according to the manufacturer's instructions (Cell Biolabs). SV40 large T immortalized *cGAS−/−* MEFs were exposed to supernatants containing cGAS-HA retroviruses and incubated overnight. Two days post transduction, 3 µg/ml puromycin was added to select a stable population of cells expressing cGAS-HA. Supernatants containing empty or UL12 M185 SPA retroviruses and 4 µg/ml polybrene were incubated with cells 5 × 10^4^ MEFs or 2 × 10^5^ BMDM in 12 well dishes for a period of 8 hours. Viral supernatants were then washed off, fresh media was added to wells, and the cells were incubated for the duration of the experiment until lysis.

Quantitative PCR {#S8}
----------------

To measure relative gene expression by qRT-PCR, total cellular RNA was isolated using RNeasy Plus RNA extraction kit (QIAGEN). Approximately 400--2000ng RNA was normalized across samples and cDNA was generated using the High Capacity cDNA RT kit (Applied Biosystems). cDNA was then subjected to qPCR using Fast SYBR Green Master Mix (Applied Biosystems) and primers as indicated on the ViiA7 Real Time PCR system (Life Technologies). Three technical replicates were performed for each biological sample, and expression values of each replicate were normalized against GAPDH cDNA using the 2^−ΔΔCt^ method. For relative expression (fold), control samples were centered at 1; for relative expression (%), control samples were centered at 100%. mtDNA copy number analysis was performed as described using primers specific to nuclear *Tert* and the D-loop region of mtDNA (listed in [Extended Data Table 1](#T1){ref-type="table"})^[@R6]^. Relative HSV-1 genome abundance was determined using primers specific for nuclear *Tert* and HSV-1 *UL30* or *TK*. Relative MHV68 genome abundance was determined using primers specific for nuclear *Tert* and MHV68 ORF40. Relative Vaccinia genome abundance was determined using primers specific for nuclear *Tert* and VV DNApol *E9L*.

Immunofluorescence Microscopy {#S9}
-----------------------------

For all microscopy images containing mtDNA nucleoids and associated panels, cells were grown on coverslips and transfected, treated, and/or infected as described. After washing in PBS, cells were fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.1% Triton X-100 in PBS for 5 min, blocked with PBS-10% FBS for 30 min, stained with primary antibodies for 60 min, and stained with secondary antibodies for 60 min. Cells were washed with PBS between each step. Coverslips were mounted with Prolong Gold anti-fade reagent containing Dapi (Molecular Probes). Cells were imaged on a Zeiss LSM 510 META with a 63X water corrected objective. A digital scan zoom of 3.0 was used to enhance magnification. Images were pseudo-colored and merged using ImageJ software (NIH). For microscopy images in [Fig. 3](#F3){ref-type="fig"}, MEFs were infected as described and fixed with 4% paraformaldehyde for 20 min. Viral GFP fluorescence and phase contrast images were captured using an Olympus IX-71 inverted scope with a 10X ([Fig. 3a](#F3){ref-type="fig"}) or 20X ([Fig. 3e](#F3){ref-type="fig"}) objective. Viral GFP images were pseudo-colored using ImageJ.

For nucleoid area quantification, approximately 10--15 unique fields of view from 10 distinct confocal images, comprising between 200--400 nucleoids, were captured at random. After incorporating scale information obtained from the LSM Image Browser (Zeiss), images were made binary and the area of each nucleoid was determined using the 'Analyze Particles' feature of ImageJ. Nucleoids were divided into the three size cutoffs, less than 200nm^2^, between 200--450nm^2^, and greater than 450nm^2^, and the percentage of nucleoids falling within each category was plotted. Percent of nucleoids \>450 nm^2^ displaying cGAS colocalization was scored by calculating nucleoid area from 5 distinct images of si-Ctrl and si-Tfam transfected cGAS-HA reconstituted MEFs as described above. Nucleoids greater than 450 nm^2^ with a substantial cGAS co-localization signal were scored as positive.

Electron Microscopy {#S10}
-------------------

MEFs grown in petri dishes and on coverslips for orientation were fixed in 2.5% gluteraldehyde in 0.1M sodium cacodylate buffer pH 7.4 for 1 hour. The cells were rinsed in sodium cacodylate and those in petri dishes were scraped and spun down in 2% agar. All samples were fixed in 1% osmium tetroxide for 1 hour, en bloc stained in 2% uranyl acetate in maleate buffer pH 5.2 for a further hour, rinsed and dehydrated in an ethanol series, and infiltrated with resin (Embed812 EMS) and baked over night at 60°C. Hardened blocks were cut using a Leica UltraCut UCT. 60nm sections were collected on formver/carbon coated grids and contrast stained using 2% uranyl acetate and lead citrate. Samples were viewed on an FEI Tencai Biotwin TEM at 80Kv. Images were taken using Morada CCD and iTEM (Olympus) software.

For mitochondrial perimeter quantification, approximately 10--15 unique EM images of each genotype were captured at random. After incorporating scale information from iTEM software, the perimeter along the outer membrane of each mitochondrion was traced and quantified using ImageJ. Mitochondria were divided into the three size cutoffs, less than 2µm, between 2--5µM, and greater than 5µm, and the percentage of mitochondria falling within each category was plotted.

Oxygen Consumption Analysis {#S11}
---------------------------

Cells were plated in XF96 plates (SeaHorse Biosciences) at 10,000 cells/well and the next day cellular O~2~ consumption was determined in a SeaHorse Bioscience XF96 extracellular flux analyzer according to manufacturer instructions. Cells were maintained at 37 degrees C in normal growth medium without serum.

Nuclear Fractionation and Western Blotting {#S12}
------------------------------------------

Whole cell extracts were solubilized in SDS lysis buffer (20 mM Tris-HCl, 1% SDS, pH 7.5, containing protease and phosphatase inhibitors), boiled for 5 minutes, and DNA was sheared by sonication. For nuclear extraction, PBS-washed cell pellets were resuspended in 10 pellet volumes of RSB buffer (10 mM NaCl, 1.5 mM CaCl~2~, 10 mM Tris-HCl pH 7.5), swelled on ice for 10 min, homogenized with a motorized Teflon pestle, and the homogenate was centrifuged at 980 *g* for 10 min to pellet nuclei. Pellets were washed 5X in PBS, SDS was then added to a final concentration of 1%, and extracts were boiled for 5 min before sonicating to shear DNA and normalizing protein concentration. Western blotting was performed using standard protocols, and Hsp60 was used as whole cell extract loading controls, while Histone 3 was probed as a nuclear loading control.

Detection of mtDNA in Cytosolic Extracts {#S13}
----------------------------------------

Digitonin extracts from MEFs and BMDM were generated largely as described^[@R47]^. WT and *Tfam+/−* MEFs (7 × 10^6^) or Tflox ERCre−/+ BMDM exposed to 4OHT for 72 hours (1 × 10^7^) were each divided into two equal aliquots, and one aliquot was resuspended in 500 µl of 50 µM NaOH and boiled for 30 minutes to solubilize DNA. 50µl 1M Tris-HCl pH 8 was added to neutralize the pH, and these extracts served normalization controls for total mtDNA. The second equal aliquots were resuspended in roughly 500 µl buffer containing 150 mM NaCl, 50 mM HEPES, pH 7.4, and 15--25 µg/ml digitonin (EMD Chemicals). The homogenates were incubated end over end for 10 minutes to allow selective plasma membrane permeabilization, then centrifuged at 980 *g* for 3 min three times to pellet intact cells. The first pellet was saved as the 'Pel' fraction for western blotting. The cytosolic supernatants were transferred to fresh tubes and spun at 17000 *g* for 10 min to pellet any remaining cellular debris, yielding cytosolic preps free of nuclear, mitochondrial, and ER contamination. DNA was then isolated from these pure cytosolic fractions using QIAQuick Nucleotide Removal Columns (QIAGEN). qPCR was performed on both whole cell extracts and cytosolic fractions using nuclear DNA primers (*Tert*) and mtDNA primers (*Dloop1-3, Cytb, 16S, Nd4*), and the Ct values obtained for mtDNA abundance for whole cell extracts served as normalization controls for the mtDNA values obtained from the cytosolic fractions. This allowed effective standardization among samples and controlled for any variations in the total amount of mtDNA in control and TFAM-deficient samples. Using this digitonin method, no nuclear *Tert* DNA was detected in the cytosolic fractions, indicating nuclear lysis did not occur.

Bioinformatic Analyses {#S14}
----------------------

Total cellular RNA from WT and *Tfam+/−* littermate MEFs was prepared using RNeasy Plus RNA extraction kits (QIAGEN) and used for the expression microarray procedure in conjunction with the Emory University Integrated Genomics Core. RNA integrity was first verified by an Agilent Bioanalyzer and then amplified, labeled, and hybridized onto Mouse Gene 1.0 ST arrays (Affymetrix) using standard protocols recommended by the manufacturer, starting from 2 µg of total RNA. Data were normalized by the RMA method using GeneSpring software (Agilent) for each biological sample in duplicate. The student's t test was used to determine statistically significant changes in expression in *Tfam+/−* MEFs relative to WTs, with a cutoff p value of 0.05^[@R48]^. Heatmaps were generated using MultiExperiment Viewer^[@R49]^.

Statistical Analyses {#S15}
--------------------

Error bars displayed throughout the manuscript represent standard error of the mean (s.e.m.) unless indicated, and were calculated from triplicate or quadruplicate technical replicates of each biological sample. For in vivo experiments, error bars were calculated from the average of triplicate technical replicates of 3--4 mice per point. Sample sizes were chosen by standard methods to ensure adequate power, and no randomization or blinding was used for animal studies. Statistical significance was determined using the unpaired student's t test; \* = p\<0.05; \*\* = p\<0.01; \*\*\* = p\<0.001; n.s., not significant (p\>0.05). Data shown are representative of two to three independent experiments, including microscopy images, western blots, and viral challenges.

Extended Data {#S16}
=============

![TFAM deficiency induces mtDNA depletion, nucleoid stress, elevated ISG expression, and augmented type I interferon responses, but does not drastically alter oxygen consumption and mt-transcription rates\
**a,** qPCR analysis of relative mtDNA copy number from WT and *Tfam+/−* MEFs. **b,** Basal oxygen consumption rate of WT and *Tfam+/−* MEFs as determined by Seahorse Bioscience XF96 Extracellular Flux assay. **c,** qRT-PCR of mtDNA-encoded rRNA (16s) and mRNA (ND6, Cytb, Cox1) transcripts in WT and *Tfam+/−* MEFs. **d-f,** Untransfected *Tfam+/−* (d) or WT MEFs transfected with control \[si-Ctrl\] or Tfam \[si-Tfam\] siRNAs (d-f) were stained with anti-Hsp60 \[Mito\] and anti-DNA \[DNA\] antibodies. Nucleoid area from multiple independent images was calculated, stratified into groups, and graphed as percentage of the total number of nucleoids counted for each sample (d). Inset panels are magnified 3X to enhance viewing of mitochondrial network and nucleoid architecture (e). TFAM and ISG mRNA expression were measured by qRT-PCR (f). **g-i,** *Tfam^flox/flox^ ERCre−* or *Tfam^flox/flox^ ERCre+* BMDM were incubated in 4OHT for 96hrs to induce TFAM depletion. Immunofluorescence staining was performed as described above (g). ISG mRNA and protein expression was monitored by qRT-PCR and western blotting (h). qRT-PCR analysis of type I interferon and *Il6* expression in 4OHT-treated Tfam flox ERCre−/+ BMDM two hours post cytosolic delivery of interferon-stimulatory DNA \[ISD\] or poly(I:C) \[PIC\] (i). Error bars indicate ± s.e.m. of triplicates and data are representative of three independent experiments.. \*=p\<0.05, \*\*=p\<0.01, \*\*\*=p\<0.001, ns=not significant. Unless noted p\<0.05.](nihms649676f5){#F5}

![TFAM deficiency promotes accumulation of cytosolic mtDNA\
**a,** WT or *Tfam+/−* MEFs were subjected to digitonin fractionation as described in the Methods and whole cell extracts \[WCE\], pellets \[Pel\], or cytosolic extracts \[Cyt\] were blotted using the indicated antibodies. **b,** DNA was extracted from digitonin extracts of WT and *Tfam+/−* MEFs or *Tfam^flox/flox^ ERCre−* or *Tfam^flox/flox^ ERCre+* BMDM incubated in 4OHT for 72hrs. Cytosolic mtDNA was quantitated via qPCR using the mt-Dloop3 primer set. Normalization was performed as described in the Methods. **c,** Samples were prepared as described in **b,** and cytosolic mtDNA was quantitated via qPCR using the indicated primer sets. Error bars indicate ± s.e.m. of triplicates and data are representative of three independent experiments.\*\*=p\<0.01, \*\*\*=p\<0.001.](nihms649676f6){#F6}

![Mitochondrial hyperfusion regulates the accumulation of mtDNA nucleoid stress in TF^D^ MEFs\
**a-b,** WT MEFs were transfected with control or TFAM siRNAs for 96hrs. Cells were fixed and processed for EM analysis (a). Mitochondrial perimeter measurements were obtained from multiple independent images, stratified into groups, and graphed as percentage of the total number of mitochondria counted for each sample (b). **c-e,** WT MEFs were transfected with control, Mfn1, and/or TFAM siRNAs for 96hrs. Cells were fixed and stained with anti-Hsp60 antibody \[Mito\] and anti-DNA antibody \[DNA\] for confocal microscopy (c). Nucleoid area from multiple independent images was calculated as previously described (d). RNA was extracted for ISG expression analysis by qRT-PCR (e). **f,** WT and *Tfam+/−* MEFs were transfected with the indicated siRNAs for 96 hours and ISG expression analyzed by qRT-PCR. Error bars indicate ± s.e.m. of triplicates and data are representative of two independent experiments. \*\*=p\<0.01, \*\*\*=p\<0.001.](nihms649676f7){#F7}

![mtDNA stress in TF^D^ MEFs and BMDM potentiates type I interferon responses to viral infection and enhances viral clearance\
**a-b,** WT and *Tfam+/−* MEFs were infected with VSV-GFP (a) or MHV68-GFP (b) and after the indicated times, cytokine and ISG mRNA expression determined by qRT-PCR, or cytokine secretion determined by ELISA. **c-f,** *Tfam^flox/flox^ ERCre−* or *Tfam^flox/flox^ ERCre+* BMDM were incubated in 4OHT for 96hrs to induce TFAM depletion. Cells were infected with HSV1-GFP (c, e-f) or VSV-GFP (d-e), incubated for the indicated times, and viral gene expression was determined by qRT-PCR (c-d) and western blotting (e), or cytokine and ISG mRNA expression determined by qRT-PCR (f). Error bars indicate ± s.e.m. of triplicates and data are representative of two independent experiments. \*\*=p\<0.01, \*\*\*=p\<0.001, ns=not significant.](nihms649676f8){#F8}

![Tissues from*Tfam+/−* mice display elevated ISG expression, and ddC abrogates mtDNA stress, ISG expression and viral resistance phenotypes of TF^D^ cells\
**a,** RNA was extracted from the liver and kidneys of 8 week old WT and *Tfam+/−* mice (n=2 each) and subjected to qRT-PCR analysis for basal ISG expression. **b-d**, Relative mtDNA copy number (b), mtDNA nucleoid area (c) and ISG expression (d) of WT and *Tfam+/−* MEFs exposed to ddC for 96hrs. **e-f**, mtDNA nucleoid area (e) and ISG expression (f) of WT MEFs transfected with control or TFAM siRNAs for 96 hrs in the presence or absence of ddC. **g-i,** *Tfam^flox/flox^ ERCre−* or *Tfam^flox/flox^ ERCre+* BMDM were incubated in 4OHT for 96hrs to induce TFAM depletion in the presence of ddC. ddC was washed out and cells allowed to recover overnight before infection. Cells were infected with VSV-GFP (g) or HSV1-GFP (h) at MOI 1, or WT BMDM transfected with poly(I:C) or ISD (i), and incubated for the indicated times. *Ifnb* expression or viral gene expression was determined by qRT-PCR. Error bars indicate ± s.e.m. of triplicates and data are representative of two independent experiments. \*=p\<0.05, \*\*=p\<0.01, \*\*\*=p\<0.001, ns=not significant. Unless noted p\<0.05.](nihms649676f9){#F9}

![Alpha- and gamma-herpesviruses induce mtDNA stress, but RNA viruses Influenza and LCMV do not\
**a,** Relative mtDNA copy number of WT MEFs 24 hours post infection with VSV-GFP, HSV1-GFP, or mock at the indicated MOIs. **b,** WT MEFs were infected with MHV68-GFP at a MOI 0.5 and after the indicated times, cells were stained and subjected to confocal microscopy or relative mtDNA copy number determined. **c,** WT MEFs were infected with HSV2, Flu-GFP, or LCMV-GFP, at a MOI 10, and after 6 hours, cells were stained and subjected to confocal microscopy. **d,** WT MEFs were infected with Vaccinia virus at a MOI 10 or 1, and after the indicated times, cells were stained and subjected to confocal microscopy or relative mtDNA copy number determined. Error bars indicate ± s.e.m. of triplicates and data are representative of two independent experiments. \*=p\<0.05, \*\*=p\<0.01, \*\*\*=p\<0.001, ns=not significant.](nihms649676f10){#F10}

![HSV1 UL12 M185 expression is sufficient to trigger mtDNA stress, TFAM depletion, and antiviral priming in BMDM; infection with UL12-deficient HSV-1 fails to induce mtDNA stress, elicits lower vaginal type I interferon responses, and spreads more readily to DRG\
**a,** WT BMDM were transduced with HSV1 UL12 M185 expressing or empty retroviruses (RV) and relative mtDNA abundance, protein expression, and ISG mRNA expression determined. **b,** WT MEFs were infected HSV1 (UL12-FLAG) or UL12-deficient HSV1 (UL12Δ + UL98-FLAG) at MOI 10 for 3 hours and analyzed by confocal microscopy. **c,** WT MEFs were infected HSV1 (UL12-FLAG) or UL12-deficient HSV1 (UL12Δ + UL98-FLAG) at MOI 2 for 24 hours and mtDNA abundance was determined by qPCR. **d,** The vaginas of WT mice (n=3 per condition) were inoculated with 10^6^ p.f.u. of HSV1 (UL12-FLAG) or UL12-deficient HSV1 (UL12Δ + UL98-FLAG), and 24 hours post infection, vaginal RNA was extracted and gene expression analyzed by qRT-PCR. **e,** Mice (n=3 per condition) were infected as previously described, and 10 days post infection, DNA from DRG was isolated for mtDNA and HSV-1 genome abundance measurements by qPCR. Error bars indicate ± s.e.m. of triplicates and data are representative of two independent experiments. \*=p\<0.05, \*\*=p\<0.01, \*\*\*=p\<0.001; unless noted p\<0.05, ns=not significant.](nihms649676f11){#F11}

![Model illustrating mtDNA stress-dependent antiviral priming\
TFAM depletion, induced genetically or during Herpes virus infection, triggers mtDNA stress, characterized by nucleoid loss and enlargement. This results in the release of fragmented mtDNA that recruits and activates peri-mitochondrial cGAS to generate the second messenger cyclic GMP-AMP (cGAMP) and activate ER-resident STING. STING then activates TBK1, which phosphorylates IRF3 to induce dimerization and nuclear translocation. Active IRF3 elevates basal gene expression of ISGs with antiviral signaling and effector functions. Signaling ISGs, such as IRF7, ISG15, STAT1, and STAT2 cooperate with IRF3 to potentiate RIG-I-like receptor (RLR), interferon-stimulatory DNA (ISD), and type I interferon (IFN-I) responses, and effector ISGs, such as IFI44, IFIT1, IFIT3, and OASL2, augment viral resistance. Both outcomes collectively and robustly boost innate antiviral defenses to dampen viral replication.](nihms649676f12){#F12}

###### Oligonucleotides utilized in qPCR

  Gene name          Forward and reverse oligo. sequences
  ------------------ --------------------------------------
  mGapdh             GACTTCAACAGCAACTCCCAC
                     TCCACCACCCTGTTGCTGTA
  mTfam              AAGGATGATTCGGCTCAGG
                     GGCTTTGAGACCTAACTGG
  mmt-16S            GTTACCCTAGGGATAACAGCGC
                     GATCCAACATCGAGGTCGTAAACC
  mmt-ND6            TTAGCATTAAAGCCTTCACC
                     CCAACAAACCCACTAACAAT
  mmt-Cytb           AGTAGACAAAGCCACCTTGA
                     CCGCGATAATAAATGGTAAG
  mmt-Cox1           GCCCCAGATATAGCATTCCC
                     GTTCATCCTGTTCCTGCTCC
  mlfna4             CTTTCCTCATGATCCTGGTAATGAT
                     AATCCAAAATCCTTCCTGTCCTTC
  mlfnb              CCCTATGGAGATGACGGAGA
                     CCCAGTGCTGGAGAAATTGT
  mll6               TGATGCACTTGCAGAAAACA
                     ACCAGAGGAAATTTTCAATAGGC
  mViperin           ATAGTGAGCAATGGCAGCCT
                     AACCTGCTCATCGAAGCTGT
  mlfit1             CAAGGCAGGTTTCTGAGGAG
                     GACCTGGTCACCATCAGCAT
  mlfit3             TTCCCAGCAGCACAGAAAC
                     AAATTCCAGGTGAAATGGCA
  mlfi44             CTGATTACAAAAGAAGACATGACAGAC
                     AGGCAAAACCAAAGACTCCA
  mlsg15             CTAGAGCTAGAGCCTGCAG
                     AGTTAGTCACGGACACCAG
  mUsp18             GAGAGGACCATGAAGAGGA
                     TAAACCAACCAGACCATGAG
  mlrf7              CAATTCAGGGGATCCAGTTG
                     AGCATTGCTGAGGCTCACTT
  mCxcl10            CCAAGTGCTGCCGTCATTTTC
                     GGCTCGCAGGGATGATTTCAA
  mStat1             CGCGCATGCAACTGGCATATAACT
                     ATGCTTCCGTTCCCACGTAGACTT
  mStat2             TGATCTCTAACAGACAGGTGG
                     CTGCATTCACTTCTAAGGACTC
  mMda5              CGGAAGTTGGAGTCAAAGC
                     TTTGTTCAGTCTGAGTCATGG
  mRig-I             GAGTACCACTTAAAGCCAGAG
                     AATCCATTTCTTCAGAGCATCC
  HSV1 ICP27 RNA     TTTCTCCAGTGCTACCTGAAGG
                     TCAACTCGCAGACACGACTCG
  HSV1 UL30 RNA      CGCGCTTGGCGGGTATTAACAT
                     TGGGTGTCCGGCAGAATAAAGC
  VSV G              CAAGTCAAAATGCCCAAGAGTCACA
                     TTTCCTTGCATTGTTCTACAGATGG
  VSV M              TATGATCCGAATCAATTAAGATATG
                     GGGACGTTTCCCTGCCATTCCGATG
  LCMV GP            TGCCTGACCAAATGGATGATT
                     CTGCTGTGTTCCCGAAACACT
  LCMV NP            CAGAAATGTTGATGCTGGACTGC
                     CAGACCTTGGCTTGCTTTACACAG
  MHV68 gDNA ORF40   TAGCCACACCTCCCACGC
                     ATTCAAGACCTGAACATAGTGC
  Vaccinia E9L       CGGCTAAGAGTTGCACATCCA
                     CTCTGCTCCATTTAGTACCGATTCT
  HSV1 gDNA TK       ATACCGACGATCTGCGACCT
                     TTATTGCCGTCATAGCGCGG
  HSV1 gDNA UL30     ATCACCGACCCGGAGAG
                     CAGGCGCTTGTTGGTGT
  m.mtDNA Dloop 1    AATCTACCATCCTCCGTGAAACC
                     TCAGTTTAGCTACCCCCAAGTTTAA
  m.mtDNA Dloop 2    CCCTTCCCCATTTGGTCT
                     TGGTTTCACGGAGGATGG
  m.mtDNA Dloop 3    TCCTCCGTGAAACCAACAA
                     AGCGAGAAGAGGGGCATT
  m.mtDNA CytB       GCTTTCCACTTCATCTTACCATTTA
                     TGTTGGGTTGTTTGATCCTG
  m.mtDNA 16S        CACTGCCTGCCCAGTGA
                     ATACCGCGGCCGTTAAA
  m.mtDNA ND4        AACGGATCCACAGCCGTA
                     AGTCCTCGGGCCATGATT
  m.nucDNA Tert      CTAGCTCATGTGTCAAGACCCTCTT
                     GCCAGCACGTTTCTCTCGTT

###### Dicer substrate siRNAs utilized

All siRNAs were predesigned by IDT and transfected at 25nM final concentration.

  Gene name                      IDT Duplex name
  ------------------------------ -----------------------
  mTfam                          MMC.RNAI.N009360.12.1
  mExoG                          MMC.RNAI.N172456.12.1
  mSting                         MMC.RNAI.N028261.12.1
  mcGas                          MMC.RNAI.N173386.12.1
  mTbk1                          MMC.RNAI.N019786.12.1
  mlrf3                          MMC.RNAI.N016849.12.1
  mMfn1                          MMC.RNAI.N024200.12.1
  Firefly luciferase (si-Ctrl)   FLuc-S1
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![*Tfam+/−* cells exhibit mtDNA stress, elevated ISG expression, and augmented type I interferon responses\
**a,** Confocal microscopy images of MEFs stained with anti-DNA (DNA) and anti-HSP60 (Mito) antibodies. **b,** Heatmaps of microarray analyses. Genes in *Tfam+/−* MEFs exhibiting statistically significant (p\<0.05), two-fold or greater increases over WT are shown. **c-d,** qRT-PCR (c) and western blots (d) of basal ISG expression in two littermate WT and *Tfam+/−* MEF lines. **e,** qRT-PCR analysis of type I interferon expression in MEFs 9 hrs post cytosolic delivery of poly(I:C). Error bars indicate ± s.e.m. of triplicates and are representative of three independent experiments. \*\*\*=p\<0.001.](nihms649676f1){#F1}

![mtDNA stress triggers ISG expression in a cGAS- and STING-dependent fashion\
**a-b,** ISG expression in *Tfam+/−* MEFs transfected with the indicated siRNAs (top panels), or WT, *cGas−/−* (a), and *Sting−/−* (b) MEFs transfected with TFAM siRNAs (bottom panels). **c-d,** ISG expression in *Tfam+/−* MEFs transfected with the indicated siRNAs for 96 hrs. **e,** Western blots of whole cell and nuclear extracts of WT and *Tfam+/−* MEFs or *Tfam flox ERCre−/+* BMDM exposed to 4OHT for 96 hrs. **f-g***cGAS−/−* MEFs reconstituted with cGAS-HA were transfected with the indicated siRNAs for 96 hrs, then stained with anti-DNA, anti-Hsp60 \[Mito\], and anti-HA antibodies and imaged. cGAS colocalization scoring was performed as described in the Methods. Error bars indicate ± s.e.m. of triplicates and are representative of three independent experiments. \*=p\<0.05, \*\*=p\<0.01, \*\*\*=p\<0.001.](nihms649676f2){#F2}

![mtDNA stress potentiates viral resistance\
**a,** Viral GFP expression in MEFs infected with HSV1-GFP or VSV-GFP at MOI 0.5 for 24 hrs. **b,** MHV68-GFP abundance in MEFs infected at MOI 0.5. **c,** LCMV Armstrong gene expression 4d after i.v. infection of WT and *Tfam+/−* mice; n=4. **d-f,** Nucleoid area (d) or ISG expression (e) of MEFs exposed to ddC for 96 hrs. ddC-exposed MEFs were infected with HSV1-GFP or VSV-GFP at MOI 0.1 and imaged after 24 hrs. Error bars represent ± s.e.m. of triplicates (b,e) or quadruplicates (c) and all panels are representative of three independent experiments. \*\*=p\<0.01, \*\*\*=p\<0.001.](nihms649676f3){#F3}

![HSV-1 induces mtDNA stress and TFAM depletion sufficient to trigger ISG expression and necessary to fully engage antiviral immunity\
**a-c,** WT MEFs were mock infected or infected with HSV1-GFP or VSV-GFP at MOI 10 for the indicated times, and imaged after staining with anti-DNA, anti-Hsp60 \[Mito\], and anti-HSV \[HSV1\] or GFP \[VSV\] antibodies (a). mtDNA nucleoid area was calculated as described in the Methods (b). Extracts were blotted as indicated (c). **d-e,** WT MEFs were transduced with HSV1 UL12 M185-FLAG-expressing or empty retroviruses (RV) and cells were stained with anti-DNA, anti-Hsp60 \[Mito\] and anti-FLAG antibody \[UL12 M185\] (d), and protein or ISG expression examined after 24 hrs (e). **f-g,** Protein and RNA expression in BMDM infected with HSV1 (UL12-FLAG) or UL12-deficient HSV1 (UL12Δ + UL98-FLAG) at MOI 2 for the indicated times,. **h,** HSV1 genome abundance in L929 cells were infected as in **f-g**. Error bars indicate ± s.e.m. of triplicates and are representative of three independent experiments. \*\*\*=p\<0.001.](nihms649676f4){#F4}
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